Access
To read this story in full you will need to login or make a payment (see right).
Letters to Nature
Nature 389, 183-186 (11 September 1997) | doi:10.1038/38284; Received 6 May 1997; Accepted 11 June 1997
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
nature jobs
Postdoctoral Research in Functional Genomics
- Harvard School of Public Health, computer science, biology, bioinformatics,
- Boston, MA
Natural Products Chemist
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Defective platelet activation in G
q-deficient mice
Stefan Offermanns2, Christopher F. Toombs3, Yi-Hui Hu1 & Melvin I. Simon
- Division of Biology 147-75, California Institute of Technology, Pasadena, California 91125, USA
- Department of Pharmacology, Amgen Inc., 1840 DeHavilland Drive, Thousand Oaks, California 91320, USA
- Present address: Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69–73, 14195 Berlin, Germany.
Correspondence to: Melvin I. Simon Correspondence and requests for materials should be addressed to M.I.S. (e-mail: Email: simonm@starbase1.caltech.edu).
Abstract
Platelets are small disc-shaped cell fragments which undergo a rapid transformation when they encounter vascular damage. They become more spherical and extrude pseudopodia, their fibrinogen receptors are activated, causing them to aggregate, they release their granule contents, and eventually form a plug which is responsible for primary haemostasis1. Activation of platelets is also implicated in the pathogenesis of unstable angina, myocardial infarction and stroke2,3. Here we show that platelets from mice deficient in the
-subunit of the heterotrimeric guanine-nucleotide-binding protein Gq are unresponsive to a variety of physiological platelet activators. As a result, G
q-deficient mice have increased bleeding times and are protected from collagen and adrenaline-induced thromboembolism. We conclude that G
q is essential for the signalling processes used by different platelet activators and that it cannot be replaced by G
i or the 
subunits of the heterotrimeric G proteins. G
q may thus be a new target for drugs designed to block the activation of platelets.
To read this story in full you will need to login or make a payment (see right).

